Home LiteratureArticle Details
PMID: 10934451 Published · ppublish English Journal Article Review

Early detection of undiagnosed diabetes mellitus: a US perspective.

Diabetes/metabolism research and reviews ·Vol. 16 ·No. 4 ·2000-00-00 ·Pages 230-6

Harris MI, Eastman RC

Abstract

Undiagnosed Type 2 diabetes has become a common condition in the US, comprising one-third of all cases of the disease. We believe that screening for and detection of undiagnosed Type 2 diabetes is an important endeavor. In this review we provide evidence that diabetes is a condition that is appropriate for population screening and detection. This includes evidence that: 1. Type 2 diabetes is a significant health problem. It affects more than 16 million adults in the US and places these individuals at high risk for serious complications of the eyes, nerves, kidneys, and cardiovascular system. 2. There is a latent phase before diagnosis of Type 2 diabetes. During this period of undiagnosed disease, risk factors for diabetic micro- and macrovascular complications are markedly elevated and diabetic complications are developing. 3. Diagnostic criteria for diabetes have been established and are based on plasma glucose values. These criteria define a group of individuals with significant hyperglycemia who also have a high frequency of risk factors for micro- and macrovascular disease. 4. The natural history of Type 2 diabetes is understood. In most patients, diabetes proceeds inexorably from genetic predisposition, through the stage of insulin resistance and hyperinsulinemia, to beta cell failure and overt clinical disease. 5. There are effective and acceptable therapies available for Type 2 diabetes and its complications. Treating hyperglycemia to prevent complications is more effective than treating these complications after they have developed. Furthermore, guidelines for treatment to prevent cardiovascular disease in people known to have diabetes are more stringent than in those individuals who are not known to have diabetes. 6. There is a suitable test for screening for undiagnosed Type 2 diabetes that has high sensitivity and specificity - measurement of fasting plasma glucose. Guidelines for identifying persons at high risk for diabetes have been established.

MeSH Terms
Blood Glucose/analysis Diabetes Mellitus, Type 2/diagnosis,epidemiology,physiopathology,therapy Diabetic Angiopathies/epidemiology,physiopathology Guidelines as Topic Humans Mass Screening United States/epidemiology
Chemicals
Blood Glucose
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Harris M I
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-5460, USA. [email protected]
Eastman R C
Article Info
Journal
Diabetes/metabolism research and reviews
Abbr.
Diabetes Metab Res Rev
ISSN
1520-7552
Published
2000-00-00
Pages
230-6
Language
English
Region
England
NLM ID
100883450
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]